49762929 - pile of blue pills, closeup
Mumbai, February 03, 2018: Pharma Major, Dr.Reddy’s Laboratories has launched Tetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine (tetrabenazine) in the United States market approved by the US Food and Drug Administration (USFDA).
The Xenazine brand and generic had US sales of around USD322 million MAT for the most recent twelve months ending in November 2017 according to IMS Health.
The company’s Tetrabenazine Tablets are available in strengths of 12.
5 mg and 25 mg, each strength is available in a bottle count size of 112.
United News of India
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…